baber/WOPTO huggingface dataset:
Patent FI-915501-A0 (FI)
Inventor: JOERGENSEN-BECK FRODE
IPC: B65D5/54
Filed: 1991-11-22
Abstract: PCT No. PCT/DK90/00128 Sec. 371 Date Jan. 22, 1992 Sec. 102(e) Date Jan. 22, 1992 PCT Filed May 22, 1990 PCT Pub. No. WO90/14278 PCT Pub. Date Nov. 29, 1990.The invention relates to a cardboard sales and dispenser box of a pocket carry-type and of a hinged hood or a cap-like lid type. The present invention provides an effective snap-locking mechanism for engaging laterally projecting ear portions on opposed side edges of a front panel portion of the dispensing boxes. The laterally projecting ear portions engage respective recesses on the inside of opposed lateral lid skirt portions. The recesses are spaced within the inner side of the front lid skirt, adjacent to the corners thereof, and the edges of the side flap portions of the lid panel are folded flat against the outer lateral lid skirt portions constructed by the side folded outer flap portions of the front lid skirt. Thus, the hinged lid is effectively snap-locked when the projecting ear portions are received in the recesses while the lid is closed.
Patent FI-920023-A0 (FI)
Inventor: HOWARD HARRY R
IPC: C07D417/12
Filed: 1992-01-03
Abstract: Compounds of the formula <CHEM> and pharmaceutical compositions comprising them, wherein R<1>, Z, X, W and Y are as defined below. The compounds are useful in the treatment of psychosis and anxiety.
Patent FI-921327-A0 (FI)
Inventor: WANNAMAKER MARION WOODS
IPC: C07D217/06
Filed: 1992-03-26
Abstract: Compounds of the formula <CHEM>  wherein     E   is O or S; G   is A-Y-B-D, A-Y-D, A-D or D1 wherein A   is a saturated C1-C14 alkylene of straight or branched chain cornfiguarion; Y   is oxygen, sulfur, sulfinyl or sulfonyl; B   is a saturated C1-C14 alkylene of straight or branched chain configuration; D   is a C1-C4 saturated or unsaturated alkyl of straight or branched chain configuration, -CF3, -CHF2, -CH2F, or phenyl; and D1   is H, -CF3, -CHF2, -CH2F, -CH3 or phenyl. are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in patients in need thereof.
Patent FI-932028-A0 (FI)
Inventor: MICKEL STUART JOHN
IPC: A61P25/00
Filed: 1993-05-05
Abstract: N-Aralkyl- and N-heteroaralkylaminoalkanephosphinic acids of the formula I <IMAGE> in which R denotes an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, araliphatic or heteroarylaliphatic radical having at least 2 C atoms, R1 represents hydrogen or hydroxyl, R2 denotes an optionally functionally modified carboxyl-substituted araliphatic or heteroarylaliphatic radical which is bonded directly or via a spacer and R3 represents hydrogen, lower alkyl or a group R2, and their salts have useful nootropic and antiepileptic properties and can be used for the preparation of a nootropic or antiepileptic medicament.
Patent FI-943797-A0 (FI)
Inventor: KLEINMAN EDWARD F
IPC: A61K31/495
Filed: 1994-08-18
Abstract: PCT No. PCT/IB94/00113 Sec. 371 Date Jan. 11, 1996 Sec. 102(e) Date Jan. 11, 1996 PCT Filed May 19, 1994 PCT Pub. No. WO95/05378 PCT Pub. Date Feb. 23, 1995Compounds of formula (I) are active antiviral compounds useful in the treatment of viral infections in mammals. The compounds of the invention are readily prepared by reaction of a suitable 2-thiothiazole derivative with an appropriate Het-(CH2)n-halide.
Patent FI-952398-A0 (FI)
Inventor: ANDERSSON LARS
IPC: B29C48/151
Filed: 1995-05-17
Abstract: PCT No. PCT/SE93/00954 Sec. 371 Date Jun. 21, 1995 Sec. 102(e) Date Jun. 21, 1995 PCT Filed Nov. 10, 1993 PCT Pub. No. WO94/11324 PCT Pub. Date May 26, 1994A low energy fuse, comprising a plastic tube with a channel, the channel containing a reactive material able upon ignition to sustain a shock wave within the channel, the tube comprising at least two layers of plastic materials, a first plastic layer closer to the channel and a second plastic layer outside the first layer, at least the second layer containing a major amount of draw orientable polymer resin. The polymer in the second layer is axially oriented to an orientation degree (as defined) of more than 25% and less than 90% and that the polymer of the first layer has an axial orientation degree not exceeding 10% orientation degree units more than that of the second layer. The tube can be manufactured by a) forming, by extrusion of the first layer plastic, the first layer in the form of a tube, b) introducing the reactive material in the tube channel, c) limiting stretching of the first layer to give a low degree of orientation, not exceeding 10% (as defined), d) forming, by extrusion of the second layer plastic, the second layer around the first tube, while the first layer have said low degree of orientation, and e) cold-stretching the first and second layers together.
Patent FI-980485-A0 (FI)
Inventor: NYKAENEN PETRI
IPC: H04L12/56
Filed: 1998-03-03
Abstract: The invention relates to a method for setting up a data transmission connection which is formed for transmitting information between at least a first communication device (1, 6-15, 300a, 300b, 400, 401) and a second communication device (1, 6-15, 300a, 300b, 400, 401), in which method, for at least the first communication device (1, 6-15, 300a, 300b, 400, 401), a network address (321a, 321b) is selected that is advantageously used for identifying the first communication device (1, 6-15, 300a, 300b, 400, 401). In the method according to the invention, for at least one service of at least the first communication device (1, 6-15, 300a, 300b, 400, 401), an address information (320a, 320b) is formed, which is advantageously used for identifying the service, and between the network address (321a, 321b) of the first communication device (1, 6-15, 300a, 300b, 400, 401) and the address information (320a, 320b) of the service, a correspondence is arranged for transferring information between the first communication device (1, 6-15, 300a, 300b, 400, 401) and the second communication device (1, 6-15, 300a, 300b, 400, 401).
Patent FI-990879-A0 (FI)
Inventor: SEVANTO JARKKO
IPC: H04L29/06
Filed: 1999-04-19
Abstract: A method is provided for transmitting multimedia-related information between a terminal and a network device. A first protocol stack (201, 202, 203, 204, 205, 206, 207) is defined for the terminal and a second protocol stack (271, 272, 273, 274, 275) is defined for the network device. The protocol stacks consist of layers and serve the arranging of the mutual exchange of information between the terminal and the network device. A second network device intermediates the transmission of multimedia-related information. An octet stream protocol layer (206, 255) is defined for the transmission of unstructured octet streams as a certain layer in the terminal protocol stack and a certain layer in the second network device's protocol stack, and a network transmission protocol layer (264, 274) is defined for the transmission of data between the network devices. A multimedia messaging transport protocol layer (207, 275) is also defined as a certain layer above the octet stream protocol layer (206) in the terminal's protocol stack and the network transmission protocol layer (274) in the first network device. Multimedia-related information is exchanged between the multimedia messaging transport protocol layer (207) in the terminal and the multimedia messaging transport protocol layer (275) in the first network device through the use of the octet stream protocol layer (206, 255), the network transmission protocol layer (264, 274) as well as other lower layers in the protocol stacks.
Patent IL-70358-A0 (IL)
Title: Compositions containing n-sulfonylimino-thiocarbonic acid diesters and method for the protection of rice crops against the phytotoxic action of herbicides
IPC: C07D249/12
Filed: 1983-12-01
Abstract: N-Sulfonyliminothiocarbonic acid diesters protect rice crops from phytotoxic damage caused by herbicides.
Patent IL-84294-A0 (IL)
Title: In vivo cellular tracking
IPC: A61B5/055
Filed: 1987-10-27
Abstract: Methods of tracking cells in vivo and for determining in vivo cell lifetimes. Cells are labelled with cyanine dyes and detection is by measuring fluorescence, absorbance, or by detecting nuclear magnetic reasonance probes included in the cyanine dyes. Using the invented methods, for example, red blood cell and platelet lifetimes are determined. Also, cells are tracked to determine sites of primary or metastatic tumors, or sites of occult infection. Further, rates at which cells pass through vessels is used to determine blood vessel patency and platelet aggregation.
Patent IL-85823-A0 (IL)
Title: 4-(4-(4-(4-((2-(2,4-difluorophenyl)-2-(1h-azolylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)triazolones,their preparation and antimicrobial compositions containing them
IPC: C07D233/60
Filed: 1988-03-23
Abstract: Novel 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4 -yl] methoxy]phenyl]-1-piperazinyl]phenyl]triazolones of formula <CHEM> wherein Q is N or CH; R is hydrogen, C1-6alkyl or arylC1-6alkyl; and R<1> is hydrogen, C1-6alkyl or arylC1-6alkyl; wherein aryl is phenyl optionally substituted with up to 3 substituents each independently selected from halo, C1-6alkyl, C1-6alkyloxy and trifluoromethyl, the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof, which compounds are anti-microbial agents; pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions.
Patent IL-88139-A0 (IL)
Title: Device for spontaneous reporting of remotely generated data
IPC: H04Q9/00
Filed: 1988-10-24
Abstract: A device (10) for spontaneously reporting remotely stored data is coupled to a descrambler (22) in an impulse pay-per-view television system for storing and reporting data pertaining to subject matter descrambled by the descrambler, such as identification of each impulse pay-per-view program that is descrambled. The descrambler (22) receives scrambled television programs over a data link (28) from a central station (24). The reporting device (10) is coupled to the central station (24) by telephone lines (26) for reporting the stored data to the central station. The reporting device (10) includes a memory (12) at the remote location for storing the generated data; and a control unit (14, 18) for causing the stored data to be spontaneously reported in response to the storage of at least a predetermined minumum amount of data, independently of responding to an interrogation signal requesting the report. The control unit (14, 18) includes a clock (18) for indicating elapsed time; and the control unit (14) processes the elapsed time indication to define time slots within which to make the reports, with predetermined time slots for the reporting of the stored data following the storage of at least the predetermined minimum amount of data being assigned by the control means in accordance with stored predetermined criteria. The control unit (14) monitors whether the stored data was successfully reported to the central station (24); and tries again to report the stored data when the stored data was not successfully reported to the central station. Upon trying again the control unit (14) causes the stored data to be reported in a different predetermined time slot than that used for the last previous unsuccessful report.
Patent IL-96767-A0 (IL)
Title: Method of making ceramic composite bodies and bodies made thereby
IPC: C04B35/65
Filed: 1990-12-23
Abstract: The present invention relates to methods for producing self-supporting ceramic and ceramic composite bodies having a protective surface region on at least a portion of the surface of the formed bodies, and bodies produced thereby. <IMAGE>
Patent SE-9403355-A0 (SE)
Title: Skarvsynkroniseringssystem
Inventor: PIPKORN ALAN J
IPC: B65H39/16
Filed: 1994-10-04
Abstract: .• •• •.• • ; .ve•▪•• e• ef• •• •9•••• • • V •••••••••14*• 0• • •a.• • 33 Sammandraq System for koordinering av skarvarna i var och en av de delbanor som anvdnds for att framstalla vid en sammansatt wellpappbana oberoende matningar pA en dynamisk, verklig tidsbasis langden av varje delbana mellan den skarvanordning, dar den frammatas och en nedstroms belagen avskArningsapparat, dar de synkroniserade skarvarna utskdres i en kort ldngd av banan, i vilken de inryms. Den verkliga tidmatningen av varje delbana innefattar kontinuerlig avkanning av banlangder utsatta for fordndring, (IA de ,-1s genom varierbara langdfOrrAdomrAden, saint en inledande procedur varigenom en initiell okand langd delbana i dess respektive fOrrAd bestdms. Systemet innefattar Aven en kalibreringsprocedur, genom vilken de olika anordningar, som anvands for att mata de frammatade banlangderna genom systemet, samtliga kalibreras till en masteranordning, som reglerar den totala banlangden for varje order. Exakthet hos systemet är ytterligare forhojt genom oberoende avkanning av svarstiden till varje skarvanordning till dess aktiveringsreglersignal och dA sA kravs justering av tidsberakningen av reglersignalen for uppmatta variationer i svarstiden.
Patent AU-PM411494-A0 (AU)
Title: Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
IPC: A61K31/047
Filed: 1994-02-25
Abstract: PCT No. PCT/AU95/00086 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Feb. 23, 1995 PCT Pub. No. WO95/22993 PCT Pub. Date Aug. 31, 1995A method as described for testing the susceptibility of a person to asthma. The person inhales an effective amount of sodium chloride, mannitol or another substance capable of altering the osmolarity of airway surface liquid in the subject. The substance is in the form of a dispersible dry powder containing an effective proportion of particles of a respirable size. The subject is then measured to detect airway narrowing which is indicative of a propensity for asthma. The same technique of dry powder inhalation can be used to test for the susceptibility of a person to rhinitus, to induce sputum and promote mucociliary clearance.
Patent AU-PO394496-A0 (AU)
Title: Biological microfistula tube and implantation method and apparatus
IPC: A61F9/007
Filed: 1996-11-29
Abstract: The present invention provides a microfistula tube including a soluble duct, defining a drainage canal having an inner surface, the duct being biocompatible, wherein the microfistula tube is coated with and/or incorporates biological for forming a basement membrane, or an intracellular matrix and a basement membrane. The biological cells may coat the inner surface of the drainage canal, and the microfistula tube may be made of a mouldable material or an absorbable material. The invention also provides an implantation system for the microfistula tube including a microfistula tube and a surgical instrument including an outer tube for penetrating body tissue, an inner tube, and an innermost rod, wherein the outer tube, the inner tube and the innermost rod are coaxial, the outer tube is adapted to receive said microfistula tube, whereby the inner tube may be used to push the microfistula tube into position and the innermost rod provides mechanical support during implantation of the microfistula tube.
Patent AU-PO688697-A0 (AU)
Title: Cleansing of a body of water
IPC: C02F1/48
Filed: 1997-05-19
Abstract: The invention provides a method of and apparatus for the removal of bacteria, microbes and other cell growth from a body of water by the application of an electromagnetic signal to a section of pipe communicable with the body of water.
Patent IL-104198-A0 (IL)
Title: Process for spinning of solution of polyamide-imides based on tolylene or meta-phenylene diisocyanates and fibers thus obtained
IPC: D06M13/07
Filed: 1992-12-21
Abstract: Process for obtaining PAI fibres by spinning PAI in solution and the fibres thus obtained. They are obtained by dry or wet spinning in dimethylalkyleneurea, followed by removal of the solvent and overdrawing at elevated temperature. The yarns and fibres obtained originate from PAI based on tolylene or meta-phenylene diisocyanate and on an aromatic acid anhydride and/or an aromatic dianhydride, and optionally on one or a number of diacidic compounds. They exhibit an excellent thermomechanical behaviour and allow access to very low filament counts.
Patent IL-109554-A0 (IL)
Title: A multi-blade knife
IPC: B26B5/00
Filed: 1994-05-04
Abstract: A multiple-blade knife for slicing food products, comprising a handle 3 and multiple blades 1 which are arranged in parallel and extend through the handle. The handle comprises further means 2 for changing and setting the desired parallel distance between the blades. <IMAGE>
Patent IL-116896-A0 (IL)
Title: Process for the manufacture of moulded articles that are partly coloured or have regions of different colours
IPC: B29C39/12
Filed: 1996-01-25
Abstract: PCT No. PCT/EP96/00244 Sec. 371 Date Jul. 30, 1997 Sec. 102(e) Date Jul. 30, 1997 PCT Filed Jan. 22, 1996 PCT Pub. No. WO96/23648 PCT Pub. Date Aug. 8, 1996For the fast and rational manufacture of moulded articles, specifically contact lenses, that are partly colored or have regions of different colors, by the casting process, measured amounts of two or more crosslinkable materials of different colors are introduced into the casting mould in the uncrosslinked stated unmixed and, after closing the casting mould, are crosslinked together. By suitably controlling the introduction of the different crosslinkable materials with regard to location and/or time the merging of the colors and the transitions between the colors in the contact lens are influenced in a controlled manner.
Patent IL-128084-A0 (IL)
Title: Conformationally constrained backbone cyclized somatostatin analogs
IPC: C07K7/64
Filed: 1997-07-30
Abstract: Novel peptide analogs are disclosed. The novel peptides are conformationally constrained backbone cyclized somatostatin analogs. Methods for synthesizing the somatostatin analogs and for producing libraries of the somatostatin analogs are also disclosed. Furthermore, pharmaceutical compositions comprising somatostatin analogs, and methods of using such compositions in the treatment of endocrine disorders, neoplasms and metabolic disorders are also disclosed.
Patent IL-134826-A0 (IL)
Title: Reflector for external light
IPC: F21V17/02
Filed: 1998-08-31
Abstract: The invention relates to a box-type reflector (1) intended for external lamps (37), in which is a tubular lamp with its socket (36), especially a high pressure discharge lamp such as a high pressure sodium vapour lamp, burns in a horizontal position, the reflector unit (1) being delimited lengthwise (30), in reference to the longitudinal axis of the lamp, by front walls (21, 21', 22, 22'), and crosswise (11) by the sidewalls (4, 4', 5, 5', 6, 6'), the transversal axis (11) defining the inside width of the sidewalls. Inside the external lamp, the reflector unit (1) is mounted longitudinally (30) moveable relative to the socket (36), and/or at least part of each reflecting sidewall (4, 4', 5, 5', 6, 6') is formed by part of the reflector or by concave metal-coated side strips which are secured tilting in an adjustable manner on the upper and/or lower longitudinal edge, so that the inclination of the side strips (14, 15) can be adjusted relative to the transversal axis (11).
Patent IL-136510-A0 (IL)
Title: Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same
IPC: C07D491/107
Filed: 1998-12-04
Abstract: Compounds represented by general formula (1) and having a selective antagonism to NK2 receptors and pharmacologically acceptable salts or derivatives thereof wherein R<1> represents optionally substituted cycloalkyl or an optionally substituted saturated heterocycle; R<2> represents aryl, etc.; A represents methylene, etc.; B represents a single bond, alkylene, etc.; D represents oxygen or sulfur; G represents alkylene, etc.; L represents -N(R<3>)- or -C(R<4>)(R<5>)- Äwherein R<3> represents aryl, etc.; R<4> represents aryl, etc.; and R<5> represents optionally aminated alkyl or -CO-R<6> (wherein R<6> represents alkyl, etc.); or R<4> and R<5> may form together a cycloalkane ring, etc.Ü; R<7> represents alkyl; Z represents two hydrogen atoms or an oxygen atom; and n is 0, 1 or 2. <CHEM>
Patent IL-137314-A0 (IL)
Title: Crosslinkable aqueous fluoropolymer based dispersions
IPC: C08F2/44
Filed: 2000-07-14
Abstract: Acrylic Modified Fluoropolymers based on vinylidene fluoride polymers are disclosed wherein the acrylic phase is capable of entering into crosslinking reactions. The final cured products provide superior solvent extractability resistance to the fluoropolymer phase.
Patent IL-137545-A0 (IL)
Title: New cytotoxic tris(oxazole)-containing macrolides
IPC: A61K31/422
Filed: 1999-01-27
Abstract: The present invention discloses new cytotoxic tris(oxazole)-containing macrolides having the formula:wherein X represents a lower alkyl; R1 and R2 represent hydrogen or lower alkyl; R3a represents hydrogen, and R3b representsor R3a and R3b together represent oxygen; R4 represents hydrogen, lower alkoxy or lower alkyl; R5 represents hydrogen, carbamoyl, or lower alkanoyl; R6a represents hydrogen, and R6b represents hydroxy, or R6a and R6b together represent oxygen; R7 represents hydrogen, lower alkyl, or hydroxymethyl; R8 represents lower alkoxy or lower alkyl; Y1 represents hydrogen or methyl, and y2 represents hydrogen, or Y1 and Y2 together represent a double bond. Also disclose are methods for treating mammals using the macrolides and pharmaceutical preparations including the macrolides.
Patent IL-142292-A0 (IL)
Title: Ion exchange tumor targeting
IPC: A61K51/00
Filed: 1999-10-12
Abstract: A compound for local, i.e. intratumoral or intracavitary administration, for targeting tumors comprising dextran, the charge of which has been modified through covalent binding of charged groups, such as charged amino acids. The compound further comprises a functional group for treating or imaging the tumor.
Patent IL-143806-A0 (IL)
Title: Pyrimidine compounds
IPC: A61K31/505
Filed: 1999-12-20
Abstract: A pyrimidine derivative of formula (I):wherein: R1 is an optional substituent as defined within; Rx is selected from halo, hydroxy, nitro, amino, cyano, mercapto, carboxy, sulphamoyl, formamido, ureido or carbamoyl or a group of formula (Ib): A-B-C- as defined within; Q1 and Q2 are independently selected from aryl, a 5- or 6-membered monocyclic moiety; and a 9- or 10-membered bicyclic heterocyclic moiety; and one or both of Q1 and Q2 bears on any available carbon atom one substituent of formula (Ia) as defined within; and Q1 and Q2 are optionally further substituted; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof; are useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
Patent IL-149562-A0 (IL)
Title: Fgf variants and methods for use thereof
IPC: C07H21/04
Filed: 2002-05-09
Abstract: A method of treating an individual (i) having abnormal bone; or (ii) afflicted with a disease or disorder related to normal or abnormal FGF receptors or a skeletal disorder; or (iii) having dysplasic bone. The method includes administering to the individual a pharmaceutical composition comprising a therapeutically effective amount of a fibroblast growth factor 9 (FGF-9) variant comprising at least one amino acid substitution in the beta 8-beta 9 loop, wherein said FGF-9 variant incorporates one of the amino acid sequences set forth in SEQ ID NO: 11, 13, 14, 15, 16 or 17.